Krs Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 8.46 Cr
- Paid Up Capital ₹ 6.73 Cr
- Company Age 24 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 13.43 Cr
- Satisfied Charges ₹ 9.55 Cr
- Revenue Growth -11.02%
- Profit Growth -74.57%
- Ebitda -41.29%
- Net Worth 2.56%
- Total Assets 13.85%
About Krs Pharmaceuticals
Krs Pharmaceuticals Private Limited (KPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 12 September 2000 and has a history of 24 years and five months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 8.46 Cr and a paid-up capital of Rs 6.73 Cr.
The company currently has active open charges totaling ₹13.43 Cr. The company has closed loans amounting to ₹9.55 Cr, as per Ministry of Corporate Affairs (MCA) records.
Koneru Rao, Narendra Balusu, Sai Balusu, and One other member serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24239TG2000PTC035234
- Company No.
035234
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Sep 2000
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Krs Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lakshmana Balusu  | Managing Director | 12-Sep-2000 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Koneru Rao | Director | 02-Nov-2009 | Current |
| Narendra Balusu | Director | 27-Aug-2004 | Current |
| Sai Balusu | Director | 13-Oct-2021 | Current |
Financial Performance of Krs Pharmaceuticals.
Krs Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 11.02% decrease. The company also saw a substantial fall in profitability, with a 74.57% decrease in profit. The company's net worth moved up by a moderate rise of 2.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Krs Pharmaceuticals?
In 2023, Krs Pharmaceuticals had a promoter holding of 84.09% and a public holding of 15.91%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ocean Pharmacoat Private LimitedNarendra Balusu, Sai Balusu and 1 more are mutual person
Cyma Life Sciences Private LimitedNarendra Balusu, Sai Balusu and 1 more are mutual person
- Blue Ribbon Technologies Private Limited
Sai Balusu is a mutual person
- Nanda Nandana Estates & Farms Private Limited
Lakshmana Balusu is a mutual person
Charges (Loans)
₹13.43 Cr
₹9.55 Cr
Charges Breakdown by Lending Institutions
- Others : 13.29 Cr
- Axis Bank Limited : 0.14 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Jun 2023 | Others | ₹5.00 Cr | Open |
| 29 Sep 2020 | Axis Bank Limited | ₹1.43 M | Open |
| 22 Feb 2018 | Others | ₹8.29 Cr | Open |
| 12 Jan 2009 | State Bank Of India | ₹8.56 Cr | Satisfied |
| 01 Sep 2003 | Andhra Pradesh State Financial Corporation | ₹7.90 M | Satisfied |
How Many Employees Work at Krs Pharmaceuticals?
Krs Pharmaceuticals has a workforce of 55 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Krs Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Krs Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
